Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Uterine Fibroids
Registry Tracks Outcomes of Artery Embolization Procedure
November 12th, 2000
The Cardiovascular and Interventional Radiology Research Foundation (CIRREF) and the Society of Cardiovascular & Interventional Radiology (SCVIR), in cooperation with the Duke Clinical Research Institute (DCRI) in North Carolina, launched the Uterine Artery Embolization (UAE) Fibroid Registry for Outcomes Data (FIBROID) in October 2000. The registry brings together scientific and technical resources through the collaborative efforts and support of a professional medical society, an academic research organization, the U.S. Food and Drug Administration, and consumers. UAE is an emerging, minimally invasive procedure performed by interventional...
Source: Medical Letter on the CDC & FDA (2000-11-12)
|
